MedPath
HSA Approval

ALVERSIME SOFT CAPSULES

SIN16773P

ALVERSIME SOFT CAPSULES

ALVERSIME SOFT CAPSULES

May 5, 2023

PHARMA-CONNECTIV PTE. LTD.

POLYMEDIC TRADING ENTERPRISE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMA-CONNECTIV PTE. LTD.
Licence HolderPOLYMEDIC TRADING ENTERPRISE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

CAPSULE

**3\. How to take ALVERSIME soft capsules** Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. _Dosage:_ ADULT: 1 soft capsule 2–3 times daily at the beginning of meals or when in pain. _Method of administration:_ This medicine is to be taken orally at the beginning of meals or when in pain. Swallow the capsule with a glass of water. **If you take more ALVERSIME soft capsules than you should:** Cases of dizziness have been reported when doses higher than recommended have been taken. Consult your doctor or pharmacist immediately. **If you forget to take ALVERSIME soft capsules** Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at your next regularly scheduled time. Do not take a double dose to make up for the forgotten dose.

ORAL

Medical Information

**1\. What ALVERSIME soft capsules is and what it is used for** This medicine is used for the symptomatic treatment of digestive pain and bloating.

**2\. What you need to know before you take ALVERSIME soft capsules** **Do not take ALVERSIME soft capsules in the following cases:** - Allergic to the active substances or to any of the excipients. - If you have already experience an adverse drug reaction after taking this medicine.

A03AX58

alverine, combinations

Manufacturer Information

POLYMEDIC TRADING ENTERPRISE PTE LTD

PHIL INTER PHARMA CO., LTD.

Active Ingredients

Alverine citrate

60mg

Alverine

Simeticone

300mg

Simethicone

Documents

Patient Information Leaflets

Alversime PIL.pdf

Approved: May 5, 2023

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ALVERSIME SOFT CAPSULES - HSA Approval | MedPath